Dr. Iwona Wallach

Computational Systems Biochemistry Group

Charité - Universitätsmedizin Berlin
Seestr. 73
13347 Berlin
Germany

phone +49 30 450 528 446
fax +49 30 450 528 937
iwona.wallachcharite.de

Research Coordinator

Education and Training

  • 1998 - 2002: Studies in Biotechnology at the University of Applied Sciences Berlin (TFH Berlin)
  • 08/2000 - 02/2001: Internship (Praxissemester) in the Cystic Fibrosis Gene Therapy Group of Prof. Dr. Charles Coutelle, Imperial College of Science, Technology and Medicine, London, Great Britain
  • 03/2002 - 09/2002: Internship for diploma thesis in the Laboratory of Molecular and Cellular Neuroscience of Prof. Dr. Paul Greengard, The Rockefeller University, New York, NY, USA
  • 11/2002 - 02/2003: Research scholar in the Laboratory of Molecular and Cellular Neuroscience of Prof. Dr. Paul Greengard, The Rockefeller University, New York, NY, USA
  • 03/2003 - 08/2007: PhD studies in the laboratory of Molecular Neonatology of Prof. Dr. Christof Dame, Charité – Universitätsmedizin Berlin, CVK
  • 09/2007 – 07/2008: Postdoc in the laboratory of Molecular Neonatology of Prof. Dr. Christof Dame, Charité – Universitätsmedizin Berlin, CVK
  • Since 09/2008: Research Coordinator in the Computational Systems Biochemistry Group

Publications

Wallach I, Zhang J, Hartmann A, van Landeghem FKH, Ivanova A, Klar M, Dame C. (2009) Erythropoietin-Receptor gene regulation in neuronal cells. Pediatr Res., 65(6):619-24. [PubMed]

Flajolet M, Wang Z, Futter M, Shen W, Nuangchamnong N, Bendor J, Wallach I, Nairn AC, Surmeier DJ, Greengard P. (2008) FGF acts as a co-transmitter through adenosine A(2A) receptor to regulate synaptic plasticity. Nat Neurosci., 11(12):1402-9. [PubMed]

Tolmachov O, Palaszewski I, Bigger B, Coutelle C. (2006) RecET driven chromosomal gene targeting to generate a RecA deficient Escherichia coli strain for Cre mediated production of minicircle DNA. BMC Biotechnol. 6(17) [PubMed]

Bigger BW, Tolmachov O, Collombet JM, Fragkos M, Palaszewski I, Coutelle C. (2001) An araC-controlled bacterial cre expression system to produce DNA minicircle vectors for nuclear and mitochondrial gene therapy. J Biol Chem. 276(25), 23018-27. [PubMed]